| 产品编号 |
英文名称 |
CAS号 |
产品规格 |
价格 |
货期 |
| ZMR-15-0446 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-pyrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-1384 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0376 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 95% (99% ee) |
[1028416-47-8] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0406 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-1379 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-1397 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[945852-48-2] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0434 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0438 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(3,5-di-tert-butyl-4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0412 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(4-methoxyphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0416 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
N/A |
50mg |
咨询 |
3-5周 |
| ZMR-15-0396 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) |
[1496637-09-2] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0821 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
[1157989-25-7] |
50mg |
咨询 |
3-5周 |
| ZMR-15-0558 |
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-5618 |
(11bS)-N,N-Bis[(R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee) |
[497883-22-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0523 |
(11bS)-N,N-Bis[(S)-(+)-1-(2-methoxyphenyl)ethyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, min. 98% |
[776316-48-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-5614 |
(11bS)-N,N-Bis[(S)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee) |
[209482-27-9] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0870 |
(11bS)-N-((R)-2,3-dihydro-1H-inden-1-yl)-N-(di-n-butylmethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-0860 |
(11bS)-N-(Diphenylmethyl)-N-(i-propyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine |
[1637749-69-9] |
500mg |
咨询 |
约4周 |
| ZMR-15-0356 |
(11bS,11'bS)-2,2'-[Oxybis(methylene)]bis[4-hydroxy-4,4'-dioxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin], 95% (99% ee) |
[1447217-75-5] |
50mg |
咨询 |
3-5周 |
| ZMR-07-0086 |
(12a,18a)-5,6,12,12a,13,18,18a,19-Octahydro-5,6-dimethyl-13,18[1',2']-benzenobisbenzimidazo [1,2-b:2',1'-d]benzo[i][2.5]benzodiazocine potassium triflate adduct |
[958004-04-1] |
100mg |
咨询 |
1-3天 |
| ZMR-08-0163 |
(1R)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol, min. 98% |
[1286189-16-9] |
100mg |
咨询 |
3-5周 |
| ZMR-08-1256 |
(1R,1''R)-3,3''-[Oxybis(methylene)]bis-[1,1'-binaphthalene]-2,2'-diol, 95% (99% ee) |
[265116-85-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-1060 |
(1R,1'R,2S,2'S)-(+)-2,2'-Di-t-butyl-2,3,2',3'-tetrahydro-1,1'-bi-1H-isophosphindole, min. 98% (R,R,S,S)-DUANPHOS |
[528814-26-8] |
100mg |
咨询 |
3-5周 |
| ZMR-15-7325 |
(1R,2R)-N,N-Bis[2-(diphenylphosphino)benzyl]cyclohexane-1,2-diamine, min. 97% |
[174758-63-5] |
1g |
咨询 |
3-5周 |
| ZMR-15-7107 |
(1R,2R)-2-Amino-1-phenylpropyldiphenylphosphine, min. 97% |
[799297-44-2] |
100mg |
咨询 |
3-5周 |
| ZMR-07-0220 |
(1R,2R)-(+)-1,2-Bis(4-cyanophenyl)ethylenediamine dihydrochloride, min. 98% |
[117903-80-7] |
100mg |
咨询 |
3-5周 |
| ZMR-07-0243 |
(1R,2R)-(+)-1,2-Bis(4-nitrophenyl)ethylenediamine dihydrochloride, min. 98% |
[117903-79-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0963 |
(1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2-diphenylphosphino-1-naphthoyl), min. 94% (R,R)-DACH-Naphthyl Trost Ligand |
[174810-09-4] |
100mg |
咨询 |
3-5周 |
| ZMR-15-0960 |
(1R,2R)-(+)-1,2-Diaminocyclohexane-N,N'-bis(2'-diphenylphosphinobenzoyl), 98% (R,R)-DACH-Phenyl Trost Ligand |
[138517-61-0] |
100mg |
咨询 |
1-3天 |
| ZMR-07-0474 |
(1R,2R)-(+)-1,2-Diphenylethylenediamine, min. 97% (R,R)-DPEN |
[35132-20-8] |
10g |
咨询 |
3-5周 |
| ZMR-07-0226 |
(1R,2R)-(+)-1,2-Bis(4-dimethylaminophenyl)ethylenediamine tetrahydrochloride, min. 98% |
[866267-84-7] |
100mg |
咨询 |
3-5周 |
| ZMR-07-0330 |
(1R,2R)-(-)-1,2-Diaminocyclohexane, 99% (R,R)-DACH |
[20439-47-8] |
1g |
咨询 |
3-5周 |
| ZMR-07-0232 |
(1R,2R)-(-)-1,2-Bis(4-hydroxyphenyl)ethylenediamine dihydrochloride, min. 98% |
[1055301-14-8] |
100mg |
咨询 |
3-5周 |
| ZMR-24-0850 |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]chromium(III) chloride |
[164931-83-3] |
1g |
咨询 |
1-3天 |
| ZMR-25-0300 |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]manganese (III) chloride, 98% (R,R)-Jacobsen Cat. |
[138124-32-0] |
1g |
咨询 |
3-5周 |
| ZMR-13-5800 |
(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride, 98% |
[250611-13-3] |
1g |
咨询 |
3-5周 |
| ZMR-14-1883 |
(1R,2R)-(-)-[N,N'-Bis(4-bromobenzyl)-1,2-cyclohexanediamino][(2E)-2-buten-1-yl]chlorosilane, min. 98% |
[804559-39-5] |
1g |
咨询 |
3-5周 |
| ZMR-07-2371 |
(1R,2R)-(-)-N-(4-toluenesulfonyl)-1,2-diphenylethylenediamine, 98% (R,R)-TsDPEN |
[144222-34-4] |
10g |
咨询 |
3-5周 |
| ZMR-07-6008 |
(1R,2R)-1,2-Bis(2-hydroxyphenyl)ethane-1,2-diamine, min. 97% |
[870991-70-1] |
1g |
咨询 |
3-5周 |
| ZMR-15-7159 |
(1R,2R)-1-(Diphenylphosphino)-1-phenylpropan-2-ammonium tetrafluoroborate, min. 97% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-7137 |
(1R,2R)-2-[(4S,11bR)-3,5-Dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]-1,2-diphenylethanamine, min. 97% |
[1469882-57-2] |
100mg |
咨询 |
3-5周 |
| ZMR-15-7110 |
(1R,2R)-2-(Diphenylphosphino)-2,3-dihydro-1H-inden-1-amine, min. 97% (10wt% in THF) |
[1091606-70-0] |
1g |
咨询 |
3-5周 |
| ZMR-15-7141 |
(1R,2R)-2-[(4S,11bR)-3,5-Dihydro-4H-dinaphtho[2,1-c:1',2'-e]phosphepin-4-yl]-1-phenylpropan-2-amine, min. 97% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-15-7102 |
(1R,2R)-2-(Diphenylphosphino)-1,2-diphenylethylamine, min. 97% |
[1091606-68-6] |
100mg |
咨询 |
3-5周 |
| ZMR-15-7153 |
(1R,2R)-2-(Diphenylphosphino)-1-aminocyclohexane, min. 97% |
[452304-59-5] |
100mg |
咨询 |
3-5周 |
| ZMR-15-7156 |
(1R,2R)-2-(Diphenylphosphino)-1,2-diphenylethylammonium tetrafluoroborate, min. 97% |
N/A |
100mg |
咨询 |
3-5周 |
| ZMR-07-0637 |
(1R,2R)-2-Benzylamino-1-cyclohexanol, min. 98% |
[141553-09-5] |
2g |
咨询 |
3-5周 |
| ZMR-07-7222 |
(1R,2R)-2-Aminocyclohexanol hydrochloride, 95% (99% ee) |
[13374-31-7] |
1g |
咨询 |
3-5周 |
| ZMR-14-1880 |
(1R,2R)-[1,2-Cyclohexanediamino-N,N'-bis(4-bromobenzyl)allylchlorosilane, min. 98% |
[546084-25-7] |
1g |
咨询 |
3-5周 |
| ZMR-07-4060 |
(1R,2R)-N,N'-Di-p-tosyl-1,2-diphenyl-1,2-ethylenediamine, min. 98% |
[121758-19-8] |
1g |
咨询 |
3-5周 |
